Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Isto gains cash boost for neocartilage allograft:

This article was originally published in Clinica

Executive Summary

Isto Technologies has gained a $750,000 US grant to fund the continued development of a tissue-engineered neocartilage allograft for the surgical repair of focal articular cartilage defects in the knee and other joints. The award from the National Institute of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, will fund research to assess the allograft in sheep. The St Louis, Missouri firm estimates that the market potential for a "superior" cartilage repair technology exceeds $1bn in the US alone. Isto is also developing an osteochondral allograft that may be more suitable for osteoarthritic lesions.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts